Annick Rousseau

3.5k total citations
74 papers, 2.5k citations indexed

About

Annick Rousseau is a scholar working on Transplantation, Oncology and Surgery. According to data from OpenAlex, Annick Rousseau has authored 74 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Transplantation, 16 papers in Oncology and 15 papers in Surgery. Recurrent topics in Annick Rousseau's work include Renal Transplantation Outcomes and Treatments (43 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Transplantation: Methods and Outcomes (9 papers). Annick Rousseau is often cited by papers focused on Renal Transplantation Outcomes and Treatments (43 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Transplantation: Methods and Outcomes (9 papers). Annick Rousseau collaborates with scholars based in France, Belgium and United States. Annick Rousseau's co-authors include Pierre Marquet, Yannick Le Meur, Aurélie Prémaud, Jean Debord, Franck Saint‐Marcoux, Lionel Rostaing, Jean‐Baptiste Woillard, Nicolas Picard, Jean-Philippe Rérolle and Guillaume Hoizey and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Annick Rousseau

72 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annick Rousseau France	30	1.6k	694	462	393	378	74	2.5k
Nicolas Picard France	29	968 0.6×	697 1.0×	261 0.6×	200 0.5×	227 0.6×	81	2.5k
Barry D. Kahan United States	26	1.3k 0.8×	376 0.5×	710 1.5×	259 0.7×	183 0.5×	53	2.1k
Iain MacPhee United Kingdom	24	1.1k 0.7×	882 1.3×	283 0.6×	168 0.4×	123 0.3×	71	2.4k
Laure Elens Belgium	33	1.4k 0.9×	1.3k 1.9×	518 1.1×	194 0.5×	111 0.3×	88	3.0k
Raymond G. Morris Australia	24	729 0.5×	666 1.0×	259 0.6×	351 0.9×	110 0.3×	92	1.8k
Joachim Grevel United States	24	955 0.6×	704 1.0×	450 1.0×	168 0.4×	102 0.3×	64	2.2k
Walid M. Awni United States	30	404 0.3×	602 0.9×	259 0.6×	138 0.4×	425 1.1×	139	3.0k
Qais Mekki United States	21	517 0.3×	438 0.6×	691 1.5×	97 0.2×	188 0.5×	28	2.3k
Gabriele Kirchner Germany	25	547 0.3×	259 0.4×	681 1.5×	54 0.1×	339 0.9×	54	2.0k
David I. Min United States	21	515 0.3×	387 0.6×	203 0.4×	113 0.3×	107 0.3×	52	1.3k

Countries citing papers authored by Annick Rousseau

Since Specialization

Citations

This map shows the geographic impact of Annick Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Rousseau more than expected).

Fields of papers citing papers by Annick Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Rousseau. The network helps show where Annick Rousseau may publish in the future.

Co-authorship network of co-authors of Annick Rousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Rousseau. A scholar is included among the top collaborators of Annick Rousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Rousseau. Annick Rousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carrier, Paul, Marie Essig, Marilyne Debette‐Gratien, et al.. (2016). Anti-hepatitis C virus drugs and kidney. World Journal of Hepatology. 8(32). 1343–1343. 17 indexed citations

Laroche, Marie‐Laure, et al.. (2016). Validation of the psychometrics properties of a French quality of life questionnaire among a cohort of renal transplant recipients less than one year. Quality of Life Research. 25(9). 2347–2359. 1 indexed citations

Abdi, Zeinab, Aurélie Prémaud, Marie Essig, et al.. (2014). Exposure to Mycophenolic Acid Better Predicts Immunosuppressive Efficacy Than Exposure to Calcineurin Inhibitors in Renal Transplant Patients. Clinical Pharmacology & Therapeutics. 96(4). 508–515. 33 indexed citations

Loustaud‐Ratti, V., Paul Carrier, Annick Rousseau, et al.. (2011). Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment. Digestive and Liver Disease. 43(11). 850–855. 12 indexed citations

Marquet, Pierre, François‐Ludovic Sauvage, V. Loustaud‐Ratti, et al.. (2010). Stability of Ribavirin Concentrations Depending on the Type of Blood Collection Tube and Preanalytical Conditions. Therapeutic Drug Monitoring. 32(2). 237–241. 9 indexed citations

Prémaud, Aurélie, Burkhard Tönshoff, Victor W. Armstrong, et al.. (2010). Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacological Research. 63(3). 216–224. 35 indexed citations

Woillard, Jean‐Baptiste, Jean-Philippe Rérolle, Nicolas Picard, et al.. (2010). Risk of diarrhoea in a long‐term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8*2 variant allele. British Journal of Clinical Pharmacology. 69(6). 675–683. 35 indexed citations

Musuamba, Flora T., Annick Rousseau, Jean‐Louis Bosmans, et al.. (2009). Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus. Clinical Pharmacokinetics. 48(11). 745–758. 46 indexed citations

Meur, Yannick Le, M. Büchler, Antoine Thierry, et al.. (2007). Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation. American Journal of Transplantation. 7(11). 2496–2503. 321 indexed citations

10.

Irtan, Sabine, Franck Saint‐Marcoux, Annick Rousseau, et al.. (2007). Population Pharmacokinetics and Bayesian Estimator of Cyclosporine in Pediatric Renal Transplant Patients. Therapeutic Drug Monitoring. 29(1). 96–102. 34 indexed citations

11.

Saint‐Marcoux, Franck, Pierre Marquet, Évelyne Jacqz-Aigrain, et al.. (2006). Patient Characteristics Influencing Ciclosporin Pharmacokinetics and Accurate Bayesian Estimation of Ciclosporin Exposure in Heart, Lung and Kidney Transplant Patients. Clinical Pharmacokinetics. 45(9). 905–922. 29 indexed citations

12.

Knoop, Christiane, Philippe Thiry, Franck Saint‐Marcoux, et al.. (2005). Tacrolimus Pharmacokinetics and Dose Monitoring After Lung Transplantation for Cystic Fibrosis and Other Conditions. American Journal of Transplantation. 5(6). 1477–1482. 39 indexed citations

13.

Rousseau, Annick, F. Léger, Yannick Le Meur, et al.. (2004). Population Pharmacokinetic Modeling of Oral Cyclosporin Using NONMEM. Therapeutic Drug Monitoring. 26(1). 23–30. 75 indexed citations

14.

Monchaud, Caroline, Annick Rousseau, F. Léger, et al.. (2003). Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0–12 monitoring in cardiac transplant recipients over the first year post-transplantation. European Journal of Clinical Pharmacology. 58(12). 813–820. 27 indexed citations

15.

Léger, F., Jean Debord, Yannick Le Meur, et al.. (2002). Maximum A Posteriori Bayesian Estimation of Oral Cyclosporin Pharmacokinetics in Patients with Stable Renal Transplants. Clinical Pharmacokinetics. 41(1). 71–80. 47 indexed citations

16.

Prémaud, Aurélie, et al.. (2002). An Animal Model for the Study of Chronopharmacokinetics of Drugs and Application to Methotrexate and Vinorelbine. Toxicology and Applied Pharmacology. 183(3). 189–197. 9 indexed citations

17.

Rousseau, Annick, et al.. (2000). Adaptive Control Methods for the Dose Individualisation of Anticancer Agents. Clinical Pharmacokinetics. 38(4). 315–353. 44 indexed citations

18.

Marquet, Pierre, et al.. (1998). Relationship between Psychotropic Drugs and Thyroid Function: A Review. Toxicology and Applied Pharmacology. 149(2). 127–135. 37 indexed citations

19.

Rousseau, Annick, et al.. (1997). Anti-Inflammatory Action of Methimazole. Pharmacology. 55(4). 173–178. 12 indexed citations

20.

Rousseau, Annick, et al.. (1993). Synthesis and Antithyroid Activity of Pyridine, Pyrimidine and Pyrazine Derivatives of Thiazole-2-thiol and 2-Thiazoline-2-thiol.. Chemical and Pharmaceutical Bulletin. 41(7). 1258–1260. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact